Continue to Cover for Atypicals in Hospitalized Pneumonia Patients
You'll hear debate about whether it's okay to use a beta-lactam ALONE in hospitalized patients with community-acquired pneumonia (CAP).
Guidelines recommend using a beta-lactam (ceftriaxone, etc) plus a macrolide (azithromycin, etc)...OR a respiratory quinolone (levofloxacin, etc)...in non-ICU CAP patients. The idea is to help cover atypicals such as Mycoplasma or Legionella.
Now new evidence suggests that beta-lactam monotherapy is associated with similar 90-day mortality as a beta-lactam/macrolide combo or respiratory quinolone monotherapy in hospitalized patients.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote